Minimum Order Quantity | 1 Bottle |
Drug Name | Sofokast Tablets |
Active Ingredient | Sofobuvir 400mg |
Dosage Form | Tablet |
Uses | The Hepatitis C Treatment Drug |
Dose/Strength | Sofobuvir 400mg |
Packaging Type | Bottle |
Composition | Sofobuvir |
Indications | The Hepatitis C Treatment Drug |
Brand | Sofokast Tablets |
Packaging Size | 28 Tablets |
Marketed By:"Aprazer ltd" ;
Indian Brand - "Sofokast Tablets" ;
Active Ingredient(s) - "Sofosbuvir Tablets" ;
Strength - "400mg" ;
Dosage Form - "Tablets" ;
Package Type - "Bottle" ;
Package Size - "28Tablets" ;
Expiry - "1 Year to 2 Years" ;
Indication(s) - "Used In The Treatment Of Hepatitis C." ;
Sofokast contain oral nucleotide analog inhibitor of the hepatitis C virus (HCV) polymerase. Chawla Medicos have been setting benchmarks of success in the market as a prominent organization engaged in offering Sofokast. These are antiviral drug, used in combination with other drugs for treatment of hepatitis C. Our expert agents source Sofokast tablets from India the trusted and certified vendors of the market. We offer these Sofokast Tablets at affordable prices to clients.
Features:
:-: Side Effects:
Packaging Size | 1*120 Bottle (120 Tablets) |
Brand | Zecyte |
Composition | Abiraterone Acetate |
Manufacturer | Cipla |
Treatment | Prostate cancer |
Prescription/Non prescription | Prescription |
Storage | Store below 30 Degree C |
Strength | 250mg |
Packaging Size | 4 x 7 tablet |
Brand | Trombopag |
Manufacturer | Natco |
Prescription/Non prescription | Prescription |
Form | Tablet |
Country of Origin | Made in India |
*Your information is safe with us.
Minimum Order Quantity | 1 Bottle |
Dosage Form | Tablets |
Dose/Strength | 90mg and 400mg |
Packaging Type | box |
Composition | Ledipasvir and sofosbuvir |
Indications | Hepatitis c virus |
Brand | Hepcvir L |
Packaging Size | 28 Tablets |
Product Description:
We have marked a well-known position in this area by providing a broad range of Hepcivir L Tablet. Owing to high demand, we offer this product in diverse packing option that meet on client’s demand .
HEPCVIR-L is a fixed-dose combination (FDC) of ledipasvir and sofosbuvir, which are direct-acting antiviral agents against the hepatitis C virus (HCV). Ledipasvir is an inhibitor of the HCV NS5A protein, which is required for viral replication. Sofosbuvir is an inhibitor of the HCV NS5B RNA-dependent RNA polymerase, which is required for viral replication. Sofosbuvir is a nucleotide prodrug that undergoes intracellular metabolism to form the pharmacologically active uridine analog triphosphate (GS-461203), which can be incorporated into HCV RNA by the NS5B polymerase and acts as a chain terminator.Hepcvir-L is the first once-a-day, fixed-dose oral combination therapy that has been approved for chronic hepatitis C genotype 1 patients. Based on a generic version of Gilead Sciences Inc’s Harvoni tablets, Hepcvir-L will be sold in India at Rs 25,000 (~US$377) for a bottle of 28 tablets.
Relative to fasting conditions, the administration of a single dose of ledipasvir -sofosbuvirFDC with a moderate fat (~600 kcal, 25% to 30% fat) or high fat (~1,000 kcal, 50% fat) meal increased sofosbuvir AUC0-inf by approximately 2-fold, but did not significantly affect sofosbuvir Cmax. The exposures of GS-331007 and ledipasvir were not altered in the presence of either meal type. The response rates in Phase 3 trials were similar in HCV-infected subjects who received ledipasvir -sofosbuvir FDC with food or without food. Ledipasvir-sofosbuvir FDC can be administered without regard to food.
Excretion
Following a single 90 mg oral dose of -ledipasvir, mean total recovery of the -radioactivity in feces and urine was approximately 87%, with most of the radioactive dose recovered from feces (approximately 86%). Unchanged ledipasvir excreted in feces accounted for a mean of 70% of the administered dose and the oxidative metabolite M19 accounted for 2.2% of the dose. These data indicate that biliary excretion of unchanged ledipasvir is a major route of elimination, with renal excretion being a minor pathway (approximately 1%). The median terminal half-life of ledipasvir following administration of ledipasvir and sofosbuvir FDC was 47 hours.
Following a single 400 mg oral dose of -sofosbuvir, mean total recovery of the dose was greater than 92%, consisting of approximately 80%, 14% and 2.5% recovered in urine, feces and expired air, respectively. The majority of the sofosbuvir dose recovered in urine was GS-331007 (78%) while 3.5% was recovered as sofosbuvir. These data indicate that renal clearance is the major elimination pathway for GS-331007. The median terminal half-lives of sofosbuvir and GS-331007 following administration of ledipasvir-sofosbuvir FDC were 0.5 and 27 hours, respectively.
Hepatic Impairment
The pharmacokinetics of ledipasvir was studied with a single dose of 90 mg ledipasvir in HCV negative subjects with severe hepatic impairment (Child-Pugh Class C). Ledipasvir plasma exposure (AUC0-inf) was similar in subjects with severe hepatic impairment and control subjects with normal hepatic function. Population pharmacokinetics analysis in HCV-infected subjects indicated that cirrhosis had no clinically relevant effect on the exposure of ledipasvir.
The pharmacokinetics of sofosbuvir wasstudied following 7-day dosing of 400 mg sofosbuvir in HCV-infected subjects with moderate and severe hepatic impairment (Child-Pugh Class B and C). Relative to subjects with normal hepatic function, the sofosbuvir AUC0-24 were 126% and 143% higher in moderate and severe hepatic impairment.
Packaging Size | 120 tablet |
Brand | Soranib |
Manufacturer | Cipla |
Prescription/Non prescription | Prescription |
Form | Tablet |
Country of Origin | Made in India |
Soranib Tablet has Sorafenib as an active ingredient. Soranib 200 mg Tablet works by backing off the rate of development of cancer cells. A powerful cancer med, Soranib 200 Mg Tablet prevents the advancement and duplication of cancer cells. Thus this drug is utilized in the treatment of thyroid cancer growth, liver, and renal cancer as well.
Before you begin utilizing the medication, give you specialist a detailed medical history of past medical issues and give him a list of hypersensitivities just as prescriptions you are using. Include every one of the medications you are taking, be it endorsed, over the counter medicine or even organic inventions.
What SORANIB 200mg is utilized for?It is utilized to treat,
Hepatocellular carcinoma (HCC, a kind of liver disease), when it can't be treated with a medical procedure
Renal cell carcinoma (RCC, a kind of kidney disease)
Brand | Tabi |
Manufacturer | Cipla |
Prescription/Non prescription | Prescription |
Form | Tablet |
Country of Origin | Made in India |
*Your information is safe with us.
Strength | 400 mg |
Brand | Glaxo SmithKline |
Packaging Type | Box |
Prescription/Non prescription | Prescription |
Dose/Strength | 400mg |
Packaging Size | 30 tablet |
Form | Tablet |
Country of Origin | Made in India |
Packaging size | 30 Tablets |
Manufacturer | hetero healthcare |
Strength | 250mg |
Brand | Hetero |
Prescription/Non prescription | Prescription |
Form | Tablet |
Ingredient | Lepatinib Tablets |
Minimum Order Quantity | 1 Strip |
Packaging Size | 7*4 |
Brand | NATCO PHARMA |
Composition | ELTROMBOPAG OLAMINE 50 MG |
Manufacturer | NATCO |
Treatment | Treat low platelet count |
Prescription/Non prescription | Prescription |
Country of Origin | Made in India |
*Your information is safe with us.
Manufactured By | Hetero Healthcare Limited |
Form | Tablet |
Packing | Pack of 60 Tablets |
Brand Name | Dyronib 70 |
Composition | Dasatinib 70mg |
Country of Origin | Made in India |
Manufacturer | Glenmark |
Prescription/Non prescription | Prescription |
Packaging Size | 1X120 |
Packaging Type | Box |
Dose/Strength | 250 Mg |
Form | Tablet |
Usage | Hospital |
Country of Origin | Made in India |
Produced by Glenmark Pharmaceuticals Ltd, Abirapro 250 mg tablet is an anticancer prescription utilized in men alongside another medication called prednisone for the treatment of prostate malignancy.
Uses of Abirapro Abiraterone TabletsAbirapro tablet is utilized together with steroid drug (prednisone or methylprednisolone) to treat prostate malignant growth that has spread to different parts of the body. It is utilized in men whose prostate malignant growth can't be treated with a medical procedure or different drugs.
What are the side-effects of Abirapro Tablet?The most usually revealed side-effects of Abirapro Tablet are diarrhea, joint swelling, hypokalemia, edema, muscle distress, and hot flush. These reactions are possible but don't generally happen. A part of the symptoms might be uncommon yet genuine. Talk to your specialist if you watch any of the accompanying symptoms, particularly if they don’t go away.
Minimum Order Quantity | 1 Bottle |
Prescription/Non prescription | Prescription |
Packaging Size | 1X120 |
Packaging Type | Bottle |
Dose/Strength (ex. 1 mg or 1 ml) | 250mg |
Usage | Personal, Clinical, Hospital |
Brand | Cipla |
Specifications:
Composition: Abiraterone Acetate Tablets
Brand: Cipla
Strength: 250 mg
Packing: 120 Tablets
Description
Xbira 250 mg tablet belongs to a class drugs known as antiandrogens. It stops the body from making testosterone which can slow the growth of prostate cancer.XBIRA 250mg – Abiraterone Acetate is a drug used in combination with prednisone in metastatic castration-resistant prostate cancer (formerly hormone-resistant prostate cancer) which is a prostate cancer not responding to androgen deprivation or treatment with anti-androgens.Abiraterone Acetate decreased serum testosterone and other androgens in patients in the placebo-controlled Phase 3 clinical trials. It is not necessary to monitor the effect of Abiraterone Acetate on serum testosterone levels.
Changes in serum prostate-specific antigen (PSA) levels may be observed, but have not been shown to correlate with clinical benefit in individual patients.
Common side effects
Anemia, Joint pain, Joint swelling, Cough, Shortness of breath, Hot flashes, Increased cholesterol level in blood, Increased glucose level in blood, Increased triglyceride level in blood, Decreased potassium level in blood, Increased blood pressure, Urinary tract infection, Weakness, Vomiting, Diarrhoea
The recommended dose of XBIRA tablets is 1000mg (four 250mg tablets) administered orally once daily in combination with Prednisone 5mg administered orally twice daily. XBIRA tablets must be taken on an empty stomach. No food should be consumed for at least 2 hours before the dose of XBIRA tablets is taken and for at least 1 hour after the dose of XBIRA tablets is taken. The tablets should be swallowed whole with water and not to be crushed or chewed. It is highly advisable to administer the drug under strict medical supervision and advice.
Expert advice FOR XBIRA
Abiraterone acetate must be taken at least one hour before or two hours after eating and never with food.
Men who take abiraterone acetate should always use effective birth control measure when having physical relationship with a woman who is or may become pregnant.
You must inform your doctor or dentist that you take abiraterone acetate before receiving any medical or dental care, emergency care, or surgery.
Before you take abiraterone acetate tell your doctor if you have high blood sugar, swelling in the feet, ankles, or legs or any effects on your bones or have taken a medicine known as ketoconazole in the past for prostate cancer.
Contact your doctor if you experience any bone pain. An increased occurrence of bone fractures has been reported in patients using abiraterone acetate.
*Your information is safe with us.
Minimum Order Quantity | 1 Box |
Dose/Strength (ex. 1 mg or 1 ml) | 100 |
Packaging Type | Box |
Packaging Size | 30 Tablets |
Prescription/Non prescription | Prescription |
Usage | Blood Cancer |
Form | Tablet |
Country of Origin | Made in India |
What is Veenat 100?
Veenat containing the active ingredient imatinib is considered a protein tyrosine kinase inhibitor type of anticancer medication. The medication works by interfering with the action of abnormal protein that signals cancer cells to multiply. It can be used to treat certain types of leukemia, certain types of skin cancer, gastrointestinal stromal tumors (GIST) and bone marrow disorders.
The active compound contained in this drug is known as a tyrosine kinase inhibitor. A key step in its mechanism of action when used for CML is the ability to inhibit the bcr-abl tyrosine kinase from triggering the phosphorylation of proteins, which is required for the cancer cells to develop. This in turn causes the destruction of the cancerous cells, allowing for the treatment of symptoms. It is generally used in cases when bone marrow transplants are not considered as the primary treatment option.
Gastrointestinal stromal tumors are treated because of the medicine`s ability to inhibit the mutant PDGFRA or KIT gene, which causes the death of abnormal cells. Other indications include acute lymphoblastic leukemia, myelodysplastic syndrome, myeloproliferative disorders, chronic eosinophilic leukemia, hypereosinophilic syndrome, DFSP (dermatofibrosarcoma protuberans) as well as other disorders that have not been referenced here.
Veenat is usually taken orally 1 to 2 times per day or as directed by a doctor. The capsules should always be taken with a meal along with a large glass of water. Contact a doctor for the correct dosage and length of treatment as it will depend on the patient’s condition and their response to the therapy. Avoid consuming grapefruits or grapefruit juice while using the medication as they can increase the risk of side effects. The capsules should be swallowed whole and not broken, chewed or crushed prior to consumption.
Dosage and Administration
The medicine content of Veenat 100 (Imatinib) is 100mg per capsule. Administration is by means of the oral route. A dosage regimen will need to be individualized for each patient, and the primary factor that the physician will consider is the condition being treated. The adult dosage for CML (in the chronic phase) is generally 400mg, administered once daily. For the accelerated phase, the physician may instruct the patient to take 600mg per day.
In cases of disease progression, the absence of an effective hematologic or cytogenic response, and certain other circumstances, the physician may decide to adjust the dosage. The adult dosage for Philadelphia chromosome positive acute lymphoblastic leukemia, systemic mastocytosis and any other condition it is used for may differ. Every patient will need to listen carefully to the dosage instructions that their physician provides them with. Physicians generally direct patients to take it alongside a full glass of water and a meal (but not on an empty stomach).
Side effects
Patients using Veenat may encounter unwanted side effects such as:
Precautions
Brand Name: Veenat 100
Generic Name: Imatinib
Form: Capsules
Manufacturer: Natco
What is Veenat 100?
Veenat containing the active ingredient imatinib is considered a protein tyrosine kinase inhibitor type of anticancer medication. The medication works by interfering with the action of abnormal protein that signals cancer cells to multiply. It can be used to treat certain types of leukemia.
Minimum Order Quantity | 1 Box |
Manufacturer | Cipla |
Prescription/Non prescription | Prescription |
Packaging Type | Box |
Usage | kidney Tablets |
Dose | 1 |
Packaging Size | 120 Tablets |
Description
Sorafenat is used for the treatment of primary kidney cancer (advanced renal cell carcinoma) and advanced primary liver cancer.
Sorafenat (sorafenib 200mg) is a cancer (chemotherapeutic) medication. Sorafenat (sorafenib 200mg) interferes with the growth of cancer cells and slows their growth and spread in the body.
Sorafenat (sorafenib 200mg) is used to treat a type of kidney cancer called advanced renal cell carcinoma. It is also used to treat liver cancer.
Sorafenat (sorafenib) is a cancer (chemotherapeutic) medication. Sorafenat interfere with the growth and spread of cancer cells in the body.
Sorafenat is used to treat a type of kidney cancer called advanced renal cell carcinoma. It is also used to treat liver cancer.
Sorafenat may also be used for purposes not listed in this medication guide.
Important information about Sorafenat
Do not use Sorafenat if you are pregnant. It could harm the unborn baby. Use effective birth control while you are using this medication and for at least 2 weeks after your treatment ends, whether you are a man or a woman. Sorafenat use by either parent may cause birth defects. Do not breast-feed while using this medication. You should not use Sorafenat if you are allergic to sorafenib, or if you have squamous cell lung cancer and you are being treated with carboplatin (Paraplatin) and paclitaxel (Onxol, Taxol, Abraxane).
Before you take Sorafenat, tell your doctor if you have kidney or liver problems (other than cancer), a bleeding or blood clotting disorder, heart disease, high blood pressure, heart disease, slow heartbeats, congestive heart failure, a personal or family history of Long QT syndrome, a history of stroke or heart attack, or any allergies.
Your blood pressure will need to be checked often. Visit your doctor regularly.
If you need surgery or dental work, tell the surgeon or dentist ahead of time that you are taking Sorafenat.
Sorafenat 200 mg tablet belongs to the class of drugs called multikinase inhibitors. It slows down the rate of growth of cancer cells by blocking the action of an abnormal protein that signals cancer cells to multiply. It cuts down the blood supply to the cancer cells and stops their growth and proliferation.It is better to take Sorafenat 200 mg tablet empty stomach (1 hour before food or 2 hours after food).
Avoid Sorafenat 200 mg tablet with high-fat meals such as olive oil, nuts & seeds (Brazil nuts), dark chocolate, butter and meat.
Expert advice FOR SORAFENAT
Usage | Commercial, Clinical |
Dose | 500mg |
Prescription/Non prescription | Prescription |
Brand | Capegard |
Form | Tablet |
Country of Origin | Made in India |
*Your information is safe with us.
Strength | 500 mg |
Packaging Type | Strip + Box |
Pack Type | Strips |
Composition | Capecitabine Tablet IP |
Manufacturer | Cipla |
Prescription/Non prescription | Prescription |
Dose/Strength | 500 mg |
Form | Tablet |
No of tablets | 10 Tablet |
Country of Origin | Made in India |
Minimum Order Quantity | 1 Bottle |
Strength | 250 mg |
Packaging Type | Box |
Packaging Size | 1X30 |
Dose | Geftinib 250mg |
Form | Tablet |
No of tablets | 30 |
Usage | Personal |
Form | Tablet |
Packaging Type | Bottle |
Manufacturer | natco |
Brand | Anastronat |
Manufactured By | Natco Pharma Ltd |
Prescription/Non prescription | Prescription |
Packaging Size | 30 tablet |
Country of Origin | Made in India |
*Your information is safe with us.
Minimum Order Quantity | 1 Bottle |
Brand | Erlonat |
Prescription/Non prescription | Prescription |
Dose | erlotinib tablet 150mg |
Packaging Size | 1X30 |
Usage | Clinical, Hospital, Personal |
Packaging Type | Bottle |
Form | Tablet |
Country of Origin | Made in India |
Minimum Order Quantity | 1 Vial |
Packaging Type | Vial |
Brand | Vivitra 150 Mg Injection |
Composition | Trastuzumab (150mg) |
Prescription/Non prescription | Prescription |
Brand Name | Vivitra 150mg Injection |
Manufactured By | Zydus Cadila |
Usage | Commercial |
Directions for Use | Your doctor or nurse will give you this medicine. Kindly do not self administer. |
Side Effect | Most side effects do not require any medical attention and disappear as your body adjusts to the med |
Storage | Store in a refrigerator (2 - 8 DegreeC). Do not freeze. |
Minimum Order Quantity | 1 |
Country of Origin | Made in India |
Minimum Order Quantity | 1 Stripe |
Brand | Alkem Laboratories Ltd |
Dose | 1mg |
Packaging Type | Strips |
Active Ingredient | Anastrozole |
Country of Origin | Made in India |
Altraz Tablet is used for the treatment of breast cancer.
SIDE EFFECTS:
*Your information is safe with us.
Minimum Order Quantity | 1 Piece |
Strength | 10.8 mg |
Packaging Type | Vial |
Brand | AstraZeneca, AstraZeneca |
Manufacturer | AstraZeneca |